Microbiota effects on cancer

From risks to therapies

Domenica Rea, Giovanni Coppola, Giuseppe Palma, Antonio Barbieri, Antonio Luciano, Paola Del Prete, Sabrina Rossetti, Massimiliano Berretta, Gaetano Facchini, Sisto Perdonà, Maria Caterina Turco, Claudio Arra

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Gut microbiota, a group of 1014 bacteria, eukaryotes and virus living in gastrointestinal tract, is crucial for many physiological processes in particular plays an important role in inflammatory and immune reactions. Several internal and external factors can influence this population, and shifts in their composition, have been demonstrated to contribute and affect different diseases. During dysbiosis several bacteria related to inflammation, one of the most necessary factors in carcinogenesis; it has been shown that some bacterial strains through deregulation of different signals/pathways may affect tumor development through the production of many factors. Gut microbiota might be considered as a holistic hub point for cancer development: direct and indirect involvements have been studying in several neoplasms such as colon rectal cancer, hepatocellular carcinoma and breast cancer. This review discuss over the evidence of crosstalk between gut microbiota and cancer, its ability to modulate chemotherapy, radiotherapy and immunotherapy, and the possibility that the intestinal microbial is a new target for therapeutic approaches to improve the prognosis and quality of life of cancer patients.

Original languageEnglish
Pages (from-to)17915-17927
Number of pages13
JournalOncotarget
Volume9
Issue number25
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Microbiota
Neoplasms
Dysbiosis
Physiological Phenomena
Bacteria
Therapeutics
Liver Neoplasms
Rectal Neoplasms
Eukaryota
Immunotherapy
Colonic Neoplasms
Gastrointestinal Tract
Hepatocellular Carcinoma
Signal Transduction
Carcinogenesis
Radiotherapy
Quality of Life
Breast Neoplasms
Viruses
Inflammation

Keywords

  • Cancer
  • Colon rectal cancer
  • Gut microbiota
  • Inflammation
  • Probiotics

ASJC Scopus subject areas

  • Oncology

Cite this

Microbiota effects on cancer : From risks to therapies. / Rea, Domenica; Coppola, Giovanni; Palma, Giuseppe; Barbieri, Antonio; Luciano, Antonio; Del Prete, Paola; Rossetti, Sabrina; Berretta, Massimiliano; Facchini, Gaetano; Perdonà, Sisto; Turco, Maria Caterina; Arra, Claudio.

In: Oncotarget, Vol. 9, No. 25, 01.04.2018, p. 17915-17927.

Research output: Contribution to journalReview article

@article{8804b4fcf9d7461e907fa81c6db6e9d2,
title = "Microbiota effects on cancer: From risks to therapies",
abstract = "Gut microbiota, a group of 1014 bacteria, eukaryotes and virus living in gastrointestinal tract, is crucial for many physiological processes in particular plays an important role in inflammatory and immune reactions. Several internal and external factors can influence this population, and shifts in their composition, have been demonstrated to contribute and affect different diseases. During dysbiosis several bacteria related to inflammation, one of the most necessary factors in carcinogenesis; it has been shown that some bacterial strains through deregulation of different signals/pathways may affect tumor development through the production of many factors. Gut microbiota might be considered as a holistic hub point for cancer development: direct and indirect involvements have been studying in several neoplasms such as colon rectal cancer, hepatocellular carcinoma and breast cancer. This review discuss over the evidence of crosstalk between gut microbiota and cancer, its ability to modulate chemotherapy, radiotherapy and immunotherapy, and the possibility that the intestinal microbial is a new target for therapeutic approaches to improve the prognosis and quality of life of cancer patients.",
keywords = "Cancer, Colon rectal cancer, Gut microbiota, Inflammation, Probiotics",
author = "Domenica Rea and Giovanni Coppola and Giuseppe Palma and Antonio Barbieri and Antonio Luciano and {Del Prete}, Paola and Sabrina Rossetti and Massimiliano Berretta and Gaetano Facchini and Sisto Perdon{\`a} and Turco, {Maria Caterina} and Claudio Arra",
year = "2018",
month = "4",
day = "1",
doi = "10.18632/oncotarget.24681",
language = "English",
volume = "9",
pages = "17915--17927",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "25",

}

TY - JOUR

T1 - Microbiota effects on cancer

T2 - From risks to therapies

AU - Rea, Domenica

AU - Coppola, Giovanni

AU - Palma, Giuseppe

AU - Barbieri, Antonio

AU - Luciano, Antonio

AU - Del Prete, Paola

AU - Rossetti, Sabrina

AU - Berretta, Massimiliano

AU - Facchini, Gaetano

AU - Perdonà, Sisto

AU - Turco, Maria Caterina

AU - Arra, Claudio

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Gut microbiota, a group of 1014 bacteria, eukaryotes and virus living in gastrointestinal tract, is crucial for many physiological processes in particular plays an important role in inflammatory and immune reactions. Several internal and external factors can influence this population, and shifts in their composition, have been demonstrated to contribute and affect different diseases. During dysbiosis several bacteria related to inflammation, one of the most necessary factors in carcinogenesis; it has been shown that some bacterial strains through deregulation of different signals/pathways may affect tumor development through the production of many factors. Gut microbiota might be considered as a holistic hub point for cancer development: direct and indirect involvements have been studying in several neoplasms such as colon rectal cancer, hepatocellular carcinoma and breast cancer. This review discuss over the evidence of crosstalk between gut microbiota and cancer, its ability to modulate chemotherapy, radiotherapy and immunotherapy, and the possibility that the intestinal microbial is a new target for therapeutic approaches to improve the prognosis and quality of life of cancer patients.

AB - Gut microbiota, a group of 1014 bacteria, eukaryotes and virus living in gastrointestinal tract, is crucial for many physiological processes in particular plays an important role in inflammatory and immune reactions. Several internal and external factors can influence this population, and shifts in their composition, have been demonstrated to contribute and affect different diseases. During dysbiosis several bacteria related to inflammation, one of the most necessary factors in carcinogenesis; it has been shown that some bacterial strains through deregulation of different signals/pathways may affect tumor development through the production of many factors. Gut microbiota might be considered as a holistic hub point for cancer development: direct and indirect involvements have been studying in several neoplasms such as colon rectal cancer, hepatocellular carcinoma and breast cancer. This review discuss over the evidence of crosstalk between gut microbiota and cancer, its ability to modulate chemotherapy, radiotherapy and immunotherapy, and the possibility that the intestinal microbial is a new target for therapeutic approaches to improve the prognosis and quality of life of cancer patients.

KW - Cancer

KW - Colon rectal cancer

KW - Gut microbiota

KW - Inflammation

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=85044824579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044824579&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.24681

DO - 10.18632/oncotarget.24681

M3 - Review article

VL - 9

SP - 17915

EP - 17927

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 25

ER -